InvestorsHub Logo
Followers 22
Posts 974
Boards Moderated 0
Alias Born 03/24/2011

Re: None

Tuesday, 11/22/2011 3:44:54 AM

Tuesday, November 22, 2011 3:44:54 AM

Post# of 110
Remedent's growth driver is China revenue.

The last 10q shows this grew about 100% to over 2 million dollars.

U.S operations are being phased out and cost reductions from the European side will start to take effect soon.

This is going to lead to large margin increases and positive EPS.

See the above Ibox for guidance in this regard.